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Mucosal surfaces are the most common route of human immunodeficiency virus type 1 (HIV-1) entry into the body. Virus inoculated onto these surfaces crosses the epithelium, likely by transcytosis [1] , where the virus encounters lamina propria mononuclear cells. These cells, or possibly other mucosal cells, presumably select from the pool of inoculated variants the macrophage-tropic species that are transmitted in mucosally acquired HIV-1 infections [2] . This selection is likely receptor mediated, but the distribution of CD4 (the primary receptor for HIV-1), CCR5 (the coreceptor for macrophage-tropic [R5] viruses), and CXCR4 (the coreceptor for lymphocyte-tropic [X4] viruses) on intestinal lamina propria cells has not been fully elucidated. The gastrointestinal mucosa, as the largest lymphoid organ in the body [3] , may be an important reservoir for HIV-1-infected cells. Furthermore, because of the local abundance of cytokines [4] and pathogens [5, 6] capable of up-regulating HIV-1 expression [7, 8] , the gastrointestinal mucosa is also a potentially important site of HIV-1 replication. However, the biological parameters of HIV-1 replication in mucosal cells also have not been fully characterized.
We recently reported that !1% of intestinal macrophages express CCR5 and that intestinal macrophages require 100-1000-fold more virus to establish infection in vitro than blood monocytes [9] . This is consistent with the remarkably low prevalence (0.06%) of HIV-1 mRNA-expressing macrophages among lamina propria mononuclear cells in the gastrointestinal tract mucosa of patients with AIDS [10] . Although intestinal macrophages appear to be down-regulated for permissiveness to HIV-1 [9] , acutely transmitted HIV-1 species are nearly always macrophage-tropic [2, [11] [12] [13] . Therefore, to determine the role of intestinal mononuclear cells in the pathogenesis of mucosal HIV-1 infection, we characterized purified primary intestinal lymphocytes and macrophages for surface CD4, CCR5, and CXCR4 expression and permissiveness to infection by macrophage-tropic and lymphocyte-tropic HIV-1.
Materials and Methods
Cell purification. Mucosal (lamina propria) lymphocytes and macrophages were harvested from normal small intestine (jejunum) from otherwise healthy organ transplantation donors in whom full circulatory and tissue integrity was maintained. Cells were isolated by two 45-min tissue digestions (37ЊC) with neutral protease (Dispase 75 mg/mL; grade I, specific activity 16 U/mg; Boehringer Mannheim, Indianapolis) and then purified by counterflow centrifugal elutriation, as previously described in detail [14, 15] . The intestinal lymphocytes that were isolated and purified by this technique displayed typical lymphocyte morphology and phenotype [14] . Intestinal macrophages isolated and purified by the same tech-nique displayed the size distribution, morphological features, ultrastructure, phagocytic activity, and phenotype of macrophages [14] . Blood lymphocytes and monocytes from the same donors were purified by counterflow centrifugal elutriation [15] and then treated with neutral protease according to the tissue digestion protocol in order for all cell populations to be treated similarly before study. Cells from each population were 195% viable prior to each experiment, as assessed by flow cytometric (FACS) analysis of propidium iodide-stained cells. To determine purity, cells were incu- 5 2 ϫ 10 bated with optimal concentrations of PerCP-CD3, PerCP-HLA-DR, PE-CD11b, PE-CD11c, PE-CD14, PE-CD34, and PE-CD123 (BD PharMingen, San Diego); FITC-CD21 (Accurate, Westbury, NY); FITC-CD103 and PE-CD83 (Immunotech, Westbrook, ME); or control PerCP-, PE-, or FITC-labeled irrelevant monoclonal antibodies of the same isotype. After staining, cells were analyzed by flow cytometry with a FACSCalibur (BD Biosciences, San Jose, CA) [14] .
Analysis of CD4 ϩ , CCR5 ϩ , and CXCR4 ϩ cell frequency. Intestinal and blood mononuclear cells were analyzed by flow cytometry for the frequency of CD4 ϩ , CCR5 ϩ , and CXCR4 ϩ cells. Cells were preincubated (15 min, 4ЊC) in PBS plus 10% normal human serum (Coulter, Miami) and 10% normal mouse serum (Jackson ImmunoResearch, West Grove, PA), and then the lymphocytes were incubated (30 min, 4ЊC) first with FITC-conjugated anti-CD4 (OrthoDiagnostics Systems, Raritan, NJ) and the macrophages/monocytes with PerCP-conjugated anti-HLA-DR(BD PharMingen). After washing, each cell population was incubated with PE-conjugated mouse monoclonal antibody (MAb) to CCR5 (clone 2D7; BD PharMingen) or PE-conjugated mouse mAb to CXCR4 (clone 12G5; BD PharMingen). FITC-, PerCP-, and PElabeled irrelevant MAbs of the same isotype were used as negative controls.
After staining, the cells were washed and resuspended in 0.2 mL 1% paraformaldehyde and stored at 4ЊC until flow cytometric analysis. To determine the effect of cell activation on coreceptor expression, intestinal macrophages were incubated with optimal concentrations of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF; 1000 U/mL; Genzyme Corp., Boston), tumor necrosis factor (TNF)-a; (100 U/mL; R&D Systems, Minneapolis), interleukin (IL)-6 (100 U/mL; R&D Systems), PMA (1 ng/mL; Sigma, St. Louis), or LPS (1 mg/mL; Sigma) for 24 h or with macrophage colony-stimulating factor (M-CSF; 1000 U/mL; R&D Systems) for 5 days and then analyzed (у10,000 events per sample) for surface CCR5 and CXCR4 by flow cytometry. The data were analyzed with CellQuest software (BD Biosciences) and expressed as the percentage of positive cells on the basis of the isotype controls.
Quantitation of CD4 ϩ , CCR5 ϩ , and CXCR4 ϩ antibody-binding sites (ABSs) by flow cytometry. The number of ABSs for CD4, CCR5, and CXCR4 on purified populations of primary intestinal and blood mononuclear cells was determined with QuantiBRITE beads and QuantiCalc software (BD Biosciences) [16] [17] [18] . Briefly, QuantiBRITE beads, containing 4 levels of PE molecules per bead, were suspended in PBS immediately before use and analyzed by FACSCalibur (BD Biosciences) to obtain a calibration curve (log PE per bead vs. log geometric mean) at a given voltage setting for PE fluorescence (FL2). Cells were stained with the highly purified PE-labeled antibodies to CD4, CCR5, and CXCR4 described above with a known PE molecule-to-antibody ratio (1:1) and analyzed at the same FL2 voltage. By use of this method, the mean fluorescence intensity of the cell sample was converted to PE copy numbers (number of ABSs per cell) by linear regression. A minimum of 10,000 events for beads and cell samples were analyzed.
Virus isolates and infectivity studies. The HIV-1 isolates used in this study included the R5 isolate BaL and the X4 isolate IIIB (ABI, Columbia, MD). The TCID 50 of each isolate was determined by end-point dilution with blood-derived macrophages for BaL and H9 cells for IIIB [9] . Before virus inoculation, purified intestinal macrophages and blood monocytes were precultured for 5 days in Dulbecco's modified Eagle medium (Mediatech, Washington, DC) plus 10% human AB serum (Atlanta Biologicals, Atlanta), antibiotics, and M-CSF (1000 U/mL; R&D Systems). Purified intestinal and blood lymphocytes were precultured for 2 days in RPMI (Mediatech) plus 10% fetal calf serum (Atlanta Biologicals), antibiotics, phytohemagglutinin (5 mg/mL; Sigma), and IL-2 (24 U/mL; R&D Systems). Cultures of intestinal or blood cells were inoculated at the indicated TCID 50 , incubated for 2 h, washed 3 times with PBS, and then cultured in 96-well plates in media (Dulbecco's modified Eagle medium without M-CSF for macrophages and monocytes and RPMI for lymphocytes) plus antibiotics and 10% fetal calf serum at a concentration of cells per 200 mL per well under 5 2 ϫ 10 standard conditions. Every 4 days, 100 mL of culture supernatant was removed and stored at Ϫ70ЊC for HIV-1 p24 antigen determination by capture assay (Coulter) and refed with 100 mL of media. At the end of each infection cycle, an aliquot of cells was stained with propidium iodide and analyzed by FACS to determine cell viability [14] . To assess the role of CCR5 in mediating R5 HIV-1 infection of intestinal lymphocytes, the lymphocytes were preincubated for 1 h with a combination of b-chemokines (regulated on activation, normal T cell expressed and secreted), macrophage inhibitory protein (MIP)-1a, and MIP-1b at a concentration of 100 ng/mL each before virus inoculation.
Results

CD4, CCR5, and CXCR4 expression on matched intestinal and blood mononuclear cells.
To determine the frequency of intestinal cells that express CD4, CCR5, and CXCR4, intestinal and control blood mononuclear cells were first isolated and purified as described above. Purified intestinal lymphocytes were routinely у95% CD103 ϩ CD3 ϩ , and blood lymphocytes were routinely 95% CD3 ϩ ; both populations contained no detectable macrophages or monocytes, respectively (figure 1). Dual fluorescence studies showed that of CD4 ϩ 85.3% ‫ע‬ 10.4% lamina propria lymphocytes were CD103 ϩ ( ). Conversely, n p 3 HLA-DR ϩ intestinal macrophages, which are CD14 Ϫ [14] , and HLA-DR ϩ blood monocytes, which are CD14 ϩ , contained no detectable lymphocytes (figure 1). The intestinal cells did not express dendritic cell markers, including CD11b, CD11c, CD21, CD34, CD83, or CD123; nor did they display ultrastructural characteristics of dendritic cells. In addition, treatment of the intestinal macrophages with optimal concentrations of GM-CSF, TNF-a, and IL-4 [19] did not induce CD83 or dendritic cell morphology. Purified intestinal lymphocytes isolated from a representative donor expressed CD4, CCR5, and CXCR4 ( figure 2, left  panels) . Among the CD4 ϩ intestinal lymphocytes, 98.5% expressed CCR5 and 98.9% expressed CXCR4. Among control CD4 ϩ blood lymphocytes from the same donor, 37.6% expressed CCR5 and 87.2% expressed CXCR4. In contrast to the intestinal lymphocytes, intestinal macrophages, which were 98% HLA-DR ϩ , expressed no detectable CCR5 or CXCR4 ( figure  2, right panels) . Control HLA-DR ϩ blood monocytes from the same donor expressed CCR5 and CXCR4 ( figure 2, insets) . The presence of CCR5 on blood monocytes (and intestinal lymphocytes and blood lymphocytes) from the same donor indicated that the absence of surface CCR5 on intestinal macrophages was not due to expression of the D32 CCR5 deletion allele. In addition, CD4
ϩ intestinal lymphocytes purified from 3 additional donors were also positive for surface CCR5 ( ) and CXCR4 ( ), whereas lamina 90.8% ‫ע‬ 5.7%
84.7% ‫ע‬ 15.4% propria macrophages from the same donors did not express detectable CCR5 or CXCR4. Incubation of the macrophages with M-CSF, GM-CSF, TNF-a, IL-6, PMA, or LPS did not induce expression of either coreceptor.
CD4, CCR5, and CXCR4 ABSs on intestinal mononuclear cells. To quantitate the number of surface CD4 and coreceptor molecules on intestinal mononuclear cells, the number of CD4, CCR5, and CXCR4 ABSs on fresh receptor-positive cells was determined by quantitative FACS analysis. As shown in table 1, intestinal lymphocytes expressed a substantial number of CD4 ABSs (mean, 14,530 ABSs/cell), albeit reduced compared with the number of CD4 ABSs on blood lymphocytes (mean, 29,176 ABSs/cell). Intestinal lymphocytes also expressed CCR5 and CXCR4 (∼2600 ABSs/cell), which was within the range of coreceptor expression on matched-blood lymphocytes (table 1) and memory T cells [18] . Intestinal macrophages also expressed CD4 (mean, 2959 ABSs/cell) at a level comparable to that of matched-blood monocytes (mean, 2247 ABSs/cell) and unmatched monocytes [18] . However, in sharp contrast to intestinal lymphocytes, intestinal macrophages displayed no detectable CCR5 or CXCR4 ABSs. The absence of surface CCR5 and CXCR4 on intestinal macrophages was not due to the isolation procedure, because both coreceptors were present on matched intestinal lymphocytes and blood mononuclear cells, which had been treated in the same isolation and purification protocol.
HIV-1 infection of intestinal lymphocytes and macrophages.
To determine the effect of coreceptor phenotype on the susceptibility of intestinal mononuclear cells to HIV-1, cultures of matched intestinal lymphocytes and macrophages were inoculated in parallel with serial dilutions of R5 (BaL) and X4 (IIIB) isolates of HIV-1. Intestinal lymphocytes supported replication by both BaL and IIIB (figure 3), consistent with their CCR5 ϩ CXCR4 ϩ phenotype. Preincubation of the cells with b chemokines, natural ligands for CCR5, completely inhibited BaL infection (figure 4), confirming that BaL infected the intestinal lymphocytes via the CCR5 coreceptor. In contrast, intestinal macrophages, which displayed no detectable CCR5 or CXCR4, did not support viral replication by either BaL or IIIB (figure 3), whereas control blood monocytes from the same donor supported high levels of replication by BaL ( figure 3,  inset) . The lack of permissiveness of intestinal macrophages to BaL was examined further with additional macrophage-tropic laboratory (ADA and DJV) and primary clinical (MDR24 and JOEL) isolates of HIV-1. When compared with matched-blood monocytes, intestinal macrophages also did not support replication by these isolates ( figure 5 ). In addition, culturing the macrophages in the presence of GM-CSF, TNF-a, IL-6, PMA, or LPS during or after exposure of the cells to HIV-1 did not result in detectable p24 production.
Because intestinal lymphocytes display many features that distinguish them from blood lymphocytes [20, 21] , we compared the levels of HIV-1 replication by intestinal lymphocytes with that of blood lymphocytes from the same donor. At each inoculation dose (TCID 50 100-1000), HIV-1-infected intestinal lymphocytes produced less p24 than blood lymphocytes. At the highest inoculation dose (TCID 50 10,000) of BaL and IIIB, intestinal lymphocytes produced up to 6000-7000 pg/mL of p24, whereas blood lymphocytes produced peak levels of 10,000 and 40,000 pg/mL, respectively. Similar differences in HIV-1 p24 production were observed when a primary isolate (JOEL) was used to infect the intestinal and blood lymphocytes. Thus, although intestinal lymphocytes were permissive to HIV-1, they produced 40%-95% less p24 antigen than infected blood lymphocytes, depending on the inoculation dose and HIV-1 isolate. In contrast, intestinal macrophages inoculated with the same doses of HIV-1 produced no detectable p24, whereas blood monocytes inoculated with BaL produced up to 180,000 pg/ mL p24. Neither intestinal macrophages nor blood monocytes supported IIIB replication, a finding consistent with the absence of CXCR4 on the macrophages shown here and the lack of biological function of the CXCR4 receptor on monocytes [22] . Thus, intestinal lymphocytes, not macrophages, support HIV-1 replication.
Discussion
The results presented here show that both lymphocytes and macrophages resident in normal human intestinal mucosa express CD4 and that intestinal lymphocytes, but not intestinal macrophages, express CCR5 and CXCR4. The absence of CCR5 molecules on intestinal macrophages was not due to expression of the D32 deletion allele, because other cell populations (blood monocytes, blood lymphocytes, and intestinal lymphocytes) from the same donors expressed CCR5. Intestinal lymphocytes supported both R5 (BaL) and X4 (IIIB) HIV-1 replication, which is consistent with their CCR5 ϩ CXCR4 ϩ phenotype, whereas the CCR5 Ϫ CXCR4 Ϫ macrophages were permissive to neither isolate nor other laboratory or primary isolates. In contrast, alveolar macrophages express low levels of CCR5 and CXCR4 and support replication by primary isolates of HIV-1 [23] . Thus, lamina propria lymphocytes, not macrophages, appear to be the coreceptor-bearing target cells equipped for HIV-1 entry in the lamina propria of the human intestinal mucosa.
The intestinal lymphocytes and macrophages used in the present study were isolated from normal small intestine because we are not yet able to purify lymphocytes and macrophages from rectum and colon. Nevertheless, the findings reported here are relevant to the vertical transmission of HIV-1 in neonates and oral transmission in homosexuals [24] and to the pathogenesis of HIV-1 mucosal infection. After virus inoculated onto a mucosal surface crosses the epithelium [1] , CD4 ϩ mononuclear cells in the underlying lamina propria presumably serve as the initial target cells for HIV-1 entry. Primary infection is followed by a prolonged period of clinical latency coinciding with high levels of viral replication in lymphoid organs [25] [26] [27] . Because the largest lymphoid organ in the body is the gastrointestinal mucosa [3] , intestinal lymphocytes and macrophages are thought to be important target cells for HIV-1 replication [8] .
However, our results suggest that during early infection, such replication occurs predominantly, if not exclusively, in lamina propria lymphocytes. The lower level of p24 production by intestinal lymphocytes compared with blood lymphocytes may reflect the relative resistance of intestinal lymphocytes to additional differentiation in vitro [21] . In addition, we could not induce intestinal macrophages to express CCR5 or become susceptible to HIV-1 by preinfecting the cells with Candida albicans or Mycobacterium avium complex (data not shown), in contrast to blood monocytes, which, after infection with M. avium complex or Pneumocystis carinii, display increased surface CCR5 and enhanced HIV-1 production [28] . Although dendritic cells play an important role in the pathogenesis of early HIV-1 infection in extraintestinal lymphoid tissue [25, 26] , their role in intestinal HIV-1 infection is less likely because, as reported here, dendritic cells appear not to be present in human intestinal lamina propria and are a rare component of human colon lamina propria [29] . Dendritic cells are present in organized lymphoid structures (i.e., Peyer's patches) of the mouse small intestine [30] , but such structures are uncommon in the proximal small intestine of adult humans. Thus, the presence of CCR5 on intestinal lymphocytes and their susceptibility to R5 virus infection suggest that after initial selection, possibly by intestinal epithelial cells, the R5 species that enters the lamina propria first infects lymphocytes.
Our finding that intestinal lymphocytes, not macrophages, are permissive to HIV-1 infection is consistent with clinical observations in both humans and macaques. In humans with AIDS, mucosal macrophages productively infected with HIV-1 are rare, with an overall prevalence of 0.06% among lamina propria mononuclear cells [10] . In addition, recent evidence indicates that the majority of cells containing HIV-1 mRNA in nongastrointestinal lymphoid tissue, such as tonsils, are not macrophages but other lymphoid mononuclear cells [26] . In macaques, simian immunodeficiency virus inoculated rectally [31] , orally [32] , or vaginally [33] first infects lymphocytes in the intestinal mucosa, and the resulting local replication occurs predominantly in lymphocytes; infected intestinal macrophages are rare during early infection [31] [32] [33] . Also in macaques, immunohistochemical staining has shown that CCR5 ϩ macro- phages constitute !1% of rectal lamina propria macrophages [34] . These in vivo observations, together with the in vitro findings reported here, indicate that resident macrophages appear to play a less important role in the pathogenesis of early mucosal HIV-1 infection than previously suspected. Rather, intestinal lymphocytes are likely the initial target cells for mucosally acquired R5 HIV-1 and the predominant source of HIV-1 production among mucosal mononuclear cells during early infection.
